Citation Impact
Citing Papers
Visualizing extravasation dynamics of metastatic tumor cells
2010
Degradation of Fibrillar Collagen in a Human Melanoma Xenograft Improves the Efficacy of an Oncolytic Herpes Simplex Virus Vector
2006 StandoutNobel
Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients
2001
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
MMP-2 Protein in Invasive Breast Cancer and the Impact of MMP-2/TIMP-2 Phenotype on Overall Survival
2003
MMP2 activation by collagen I and concanavalin A in cultured human hepatic stellate cells
1999
Tumors are unique organs defined by abnormal signaling and context
2001
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
Openings between Defective Endothelial Cells Explain Tumor Vessel Leakiness
2000
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer
2005
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
Prodrug Strategies in Anticancer Chemotherapy
2007
Three-dimensional Type I Collagen Lattices Induce Coordinate Expression of Matrix Metalloproteinases MT1-MMP and MMP-2 in Microvascular Endothelial Cells
1998
The biology and function of fibroblasts in cancer
2016 Standout
Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation
1998
Angiogenesis in cancer and other diseases
2000 StandoutNature
The Hallmarks of Cancer
2000 Standout
Complex networks orchestrate epithelial–mesenchymal transitions
2006 Standout
Localization of the Functional Domains of Human Tissue Inhibitor of Metalloproteinases-3 and the Effects of a Sorsby's Fundus Dystrophy Mutation
1998
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Enhanced Tumor Growth and Invasiveness in Vivo by a Carboxyl-Terminal Fragment of α1-Proteinase Inhibitor Generated by Matrix Metalloproteinases
1999
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Diminished Matrix Metalloproteinase 2 (MMP-2) in Ectomesenchyme-Derived Tissues of the Patch Mutant Mouse: Regulation of MMP-2 by PDGF and Effects on Mesenchymal Cell Migration
1999
Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kγ
2000 StandoutNatureNobel
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
2000 Standout
The microenvironment of the tumour–host interface
2001 StandoutNature
Remodelling the extracellular matrix in development and disease
2014 Standout
Global alterations in mRNA polysomal recruitment in a cell model of colorectal cancer progression to metastasis
2006
The Discoidin Domain Receptor Tyrosine Kinases Are Activated by Collagen
1997
Three-dimensional tissue culture models in cancer biology
2005
Molecular regulation of vessel maturation
2003 Standout
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
2007 StandoutNatureNobel
Reduced metastasis of transgenic mammary cancer in urokinase-deficient mice
2004
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Matrix metalloproteinase inhibition: A review of anti-tumour activity
1995
Microenvironmental regulation of metastasis
2008 Standout
Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation
2005
Timp-1 Is Important for Epithelial Proliferation and Branching Morphogenesis during Mouse Mammary Development
1999
Dysregulated pH: a perfect storm for cancer progression
2011 Standout
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
2013 Standout
Biomarkers for epithelial-mesenchymal transitions
2009 Standout
A matrix metalloproteinase expressed on the surface of invasive tumour cells
1994 StandoutNature
Idiopathic pulmonary fibrosis
2011 Standout
Matrix metalloproteinases in tumor invasion and metastasis
2000
NF-κB functions as a tumour promoter in inflammation-associated cancer
2004 StandoutNature
Fibroblasts in cancer
2006 Standout
Tumor-specific expression of αvβ3 integrin promotes spontaneous metastasis of breast cancer to bone
2006
Matrix metalloproteinases: multifunctional contributors to tumor progression
2000
Polymyositis and dermatomyositis
2003 Standout
Asymmetric Multicomponent Reactions (AMCRs): The New Frontier
2005 Standout
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
2012 StandoutNobel
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Heterotypic Signaling between Epithelial Tumor Cells and Fibroblasts in Carcinoma Formation
2001
Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis
2004
Matrix Metalloproteinases
1999 Standout
Iron-Catalyzed Reactions in Organic Synthesis
2004 Standout
Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies
2000
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment?
2000
Tumor Cell Interactions with the Extracellular Matrix During Invasion and Metastasis
1993
A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility.
2001
VEGF Secreted by Hypoxic Müller Cells Induces MMP-2 Expression and Activity in Endothelial Cells to Promote Retinal Neovascularization in Proliferative Diabetic Retinopathy
2013 StandoutNobel
The extracellular matrix: A dynamic niche in cancer progression
2012 Standout
Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy
2004 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer.
1993
Treatment of colorectal liver metastases by adenoviral transfer of tissue inhibitor of metalloproteinases-2 into the liver tissue.
2000
Making the cut: Protease-mediated regulation of angiogenesis
2006
Space–time control of free induction decay in the extreme ultraviolet
2017 StandoutNobel
Matrix Metalloproteinases Increase Very Early during Experimental Focal Cerebral Ischemia
1999
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Role of interleukin 10 and transforming growth factor beta1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice.
1999
CHANGES IN COLLAGEN METABOLISM IN PROSTATE CANCER: A HOST RESPONSE THAT MAY ALTER PROGRESSION
2001
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
High-spectral-resolution attosecond absorption spectroscopy of autoionization in xenon
2014
In Vivo Evidence That the Stromelysin-3 Metalloproteinase Contributes in a Paracrine Manner to Epithelial Cell Malignancy
1998
High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase.
2001
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
Ischemic Cell Death in Brain Neurons
1999 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Preterm labor: One syndrome, many causes
2014 StandoutScience
Reduction of wound angiogenesis in patients treated with BMS-275291, a broad spectrum matrix metalloproteinase inhibitor.
2003
Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors
1999
Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region.
1999
Works of Robert E. Hewitt being referenced
Repression of NHE1 Expression by PPARγ Activation Is a Potential New Approach for Specific Inhibition of the Growth of Tumor Cells In vitro and In vivo
2009
The Activation, Expression and Function of Gelatinase A (MMP-2).
1996
Stromal Cell Expression of Components ofMatrix-Degrading Protease Systems inHuman Cancer
1996
Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours
1991
MMP-2: Expression, Activation and Inhibition
1996
Relationships between epithelial basement membrane staining patterns in primary colorectal carcinomas and the extent of tumour spread
1991
Regional variations of urokinase‐type plasminogen activator in human colorectal cancer: A quantitative study by image analysis
1995
Laminin and collagen IV subunit distribution in normal and neoplastic tissues of colorectum and breast
1997
Desmoplasia and its relevance to colorectal tumour invasion
1993
Molecular regulation of cellular invasion— role of gelatinase A and TIMP-2
1996
Validation of a model of colon cancer progression
2000
Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic
1996
Validation of a model of colon cancer progression
2000
The Gibbs-Wilbraham phenomenon: An episode in fourier analysis
1979